Journal of Clinical Pediatrics ›› 2023, Vol. 41 ›› Issue (12): 887-894.doi: 10.12372/jcp.2023.23e0916
• Expert Review • Previous Articles Next Articles
GAO Chunlin
Received:2023-09-18
Published:2023-12-15
Online:2023-12-04
GAO Chunlin. Renal pathologic classification and treatment strategy in children with lupus nephritis[J].Journal of Clinical Pediatrics, 2023, 41(12): 887-894.
| [1] |
Kamphuis S, Silverman ED. Prevalence and burden of pediatric-onset systemic lupus erythematosus[J]. Nat Rev Rheumatol, 2010, 6(9): 538-546.
doi: 10.1038/nrrheum.2010.121 pmid: 20683438 |
| [2] |
Feldman CH, Broder A, Guan H, et al. Sex differences in health care utilization, end-stage renal disease, and mortality among medicaid beneficiaries with incident lupus nephritis[J]. Arthritis Rheumatol, 2018, 70(3): 417-426.
doi: 10.1002/art.v70.3 |
| [3] |
Fujikawa S, Okuni M. A nationwide surveillance study of rheumatic diseases among Japanese children[J]. Acta Paediatr Jpn, 1997, 39: 242-244.
doi: 10.1111/ped.1997.39.issue-2 |
| [4] |
Tsioni V, Andreoli L, Meini A, et al. The prevalence and incidence of systemic lupus erythematosus in children and adults: a population-based study in a mountain community in northern Italy[J]. Clin Exp Rheumatol, 2015, 33(5): 681-687.
pmid: 26089119 |
| [5] |
Ambrose N, Morgan TA, Galloway J, et al. Differences in disease phenotype and severity in SLE across age groups[J]. Lupus, 2016, 25(14): 1542-1550.
pmid: 27147622 |
| [6] |
Massias JS, Smith EMD, Al-Abadi E, et al. Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups[J]. Lupus, 2020, 29(5): 474-481.
doi: 10.1177/0961203320909156 pmid: 32233733 |
| [7] |
Hiraki LT, Feldman CH, Liu J, et al. Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US medicaid beneficiary population[J]. Arthritis Rheum, 2012, 64: 2669-2676.
doi: 10.1002/art.v64.8 |
| [8] |
Massias JS, Smith EM, Al-Abadi E, et al. Clinical and laboratory phenotypes in juvenile-onset systemic lupus erythematosus across ethnicities in the UK[J]. Lupus, 2021, 30(4): 597-607.
doi: 10.1177/0961203320984251 pmid: 33413005 |
| [9] |
Sassi RH, Hendler JV, Piccoli GF, et al. Age of onset influences on clinical and laboratory profile of patients with systemic lupus erythematosus[J]. Clin Rheumatol, 2017, 36(1): 89-95.
doi: 10.1007/s10067-016-3478-4 pmid: 27858177 |
| [10] |
Wang SF, Chen YH, Chen DQ, et al. Mesangial proliferative lupus nephritis with podocytopathy: a special entity of lupus nephritis[J]. Lupus, 2018, 27(2): 303-311.
doi: 10.1177/0961203317720526 pmid: 28720048 |
| [11] |
Oni L, Wright RD, Marks S, et al. Kidney outcomes for children with lupus nephritis[J]. Pediatr Nephrol, 2021, 36: 1377-1385.
doi: 10.1007/s00467-020-04686-1 |
| [12] |
Houssiau FA, Vasconcelos C, D'Cruz D, et al. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial[J]. Arthritis Rheum, 2004, 50(12): 3934-3940.
doi: 10.1002/art.v50:12 |
| [13] |
Anders HJ, Saxena R, Zhao MH, et al. Lupus nephritis[J]. Nat Rev Dis Primers, 2020, 6(1): 7.
doi: 10.1038/s41572-019-0141-9 |
| [14] | Lu R, Robertson JM, Bruner BF, et al. Multiple autoantibodies display association with lymphopenia, proteinuria, and cellular casts in a large, ethnically diverse SLE patient cohort[J]. Autoimmune Dis, 2012: 819634 |
| [15] | Santacruz JC, Mantilla MJ, Rueda I, et al. A practical perspective of the hematologic manifestations of systemic lupus erythematosus[J]. Cureus, 2022, 14(3): e22938. |
| [16] |
Fayyaz A, Igoe A, Kurien BT, et al. Haematological manifestations of lupus[J]. Lupus Sci Med, 2015, 2(1): e000078.
doi: 10.1136/lupus-2014-000078 |
| [17] |
Kocheril AP, Vettiyil GI, George AS, et al. Pediatric systemic lupus erythematosus with lupus anticoagulant hypoprothrombinemia syndrome-a case series with review of literature[J]. Lupus, 2021, 30(4): 641-648.
doi: 10.1177/0961203321988934 pmid: 33509039 |
| [18] |
Suyama Y, Okada M, Rokutanda R, et al. Safety and efficacy of upfront graded administration of trimethoprim-sulfamethoxazole in systemic lupus erythematosus: a retrospective cohort study[J]. Mod Rheumatol, 2016, 26(4): 557-561.
doi: 10.3109/14397595.2015.1112467 pmid: 26587755 |
| [19] |
Fanouriakis A, Kostopoulou M, Cheema K, et al. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis[J]. Ann Rheum Dis, 2020, 79(6): 713-723.
doi: 10.1136/annrheumdis-2020-216924 pmid: 32220834 |
| [20] |
Kidney Disease: Improving Global Outcomes KDIGO Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular Diseases[J]. Kidney Int, 2021, 100(4S): S1-S276.
doi: 10.1016/j.kint.2021.05.021 pmid: 34556256 |
| [21] |
Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus[J]. Ann Rheum Dis, 2019, 78(9): 1151-1159.
doi: 10.1136/annrheumdis-2018-214819 pmid: 31383717 |
| [22] | 中华医学会儿科分会肾脏学组. 儿童狼疮性肾炎诊治循证指南(2016)[J]. 中华儿科杂志, 2018, 56(2): 88-94. |
| [23] |
Wakiguchi H, Takei S, Kubota T, et al. Treatable renal disease in children with silent lupus nephritis detected by baseline biopsy: association with serum C3 levels[J]. Clin Rheumatol, 2017, 36(2): 433-437.
doi: 10.1007/s10067-016-3491-7 pmid: 27900491 |
| [24] |
Narváez J, Ricse M, Gomà M, et al. The value of repeat biopsy in lupus nephritis flares[J]. Medicine (Baltimore), 2017, 96(24): e7099.
doi: 10.1097/MD.0000000000007099 |
| [25] |
Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited[J]. Kidney Int, 2004, 65(2): 521-530.
doi: 10.1111/j.1523-1755.2004.00443.x pmid: 14717922 |
| [26] |
Bajema IM, Wilhelmus S, Alpers CE, et al. Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices[J]. Kidney Int, 2018, 93(4): 789-796.
doi: S0085-2538(17)30859-1 pmid: 29459092 |
| [27] |
Hu W, Chen Y, Wang S, et al. Clinical-morphological features and outcomes of lupus podocytopathy[J]. Clin J Am Soc Nephrol, 2016, 11(4): 585-592.
doi: 10.2215/CJN.06720615 |
| [28] |
Lee SJ, Silverman E, Bargman JM. The role of antimalarial agents in the treatment of SLE and lupus nephritis[J]. Nat Rev Nephrol, 2011, 7(12): 718-729.
doi: 10.1038/nrneph.2011.150 |
| [29] |
Yusuf IH, Charbel Issa P, Ahn SJ. Hydroxychloroquine-induced retinal toxicity[J]. Front Pharmacol, 2023, 14: 1196783.
doi: 10.3389/fphar.2023.1196783 |
| [30] |
Anders HJ, Loutan J, Bruchfeld A, et al. The management of lupus nephritis as proposed by EULAR/ERA 2019 versus KDIGO 2021[J]. Nephrol Dial Transplant, 2023, 38(3): 551-561.
doi: 10.1093/ndt/gfab351 |
| [31] |
Houssiau FA, Vasconcelos C, D'Cruz D, et al. The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide[J]. Ann Rheum Dis, 2010, 69(1): 61-64.
doi: 10.1136/ard.2008.102533 pmid: 19155235 |
| [32] |
Appel GB, Contreras G, Dooley MA, et al. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis[J]. J Am Soc Nephrol, 2009, 20: 1103-1112.
doi: 10.1681/ASN.2008101028 pmid: 19369404 |
| [33] |
Yang TH, Wu TH, Chang YL, et al. Cyclosporine for the treatment of lupus nephritis in patients with systemic lupus erythematosus[J]. Clin Nephrol, 2018, 89: 277-285.
doi: 10.5414/CN109325 |
| [34] |
Ginzler EM, Dooley MA, Aranow C, et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis[J]. N Engl J Med, 2005, 353: 2219-2228.
doi: 10.1056/NEJMoa043731 |
| [35] |
Chan TM, Tse KC, Tang CS, et al. Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine[J]. Lupus, 2005, 14: 265-272.
doi: 10.1191/0961203305lu2081oa pmid: 15864912 |
| [36] |
Zhang M, Qi C, Zha Y, et al. Leflunomide versus cyclophosphamide in the induction treatment of proliferative lupus nephritis in Chinese patients: a randomized trial[J]. Clin Rheumatol, 2019, 38: 859-867.
doi: 10.1007/s10067-018-4348-z pmid: 30426311 |
| [37] |
Furie R, Rovin BH, Houssiau F, et al. Safety and efficacy of belimumab in patients with lupus nephritis open-label extension of BLISS-LN study[J]. Clin J Am Soc Nephrol, 2022, 17: 1620-1630.
doi: 10.2215/CJN.02520322 |
| [38] |
Austin HA, 3rd, Illei GG, Braun MJ, et al. Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy[J]. J Am Soc Nephrol, 2009, 20: 901-911.
doi: 10.1681/ASN.2008060665 pmid: 19297556 |
| [39] |
Wasik H, Chadha V, Galbiati S, et al. Dialysis outcomes for children with lupus nephritis compared to children with other forms of nephritis: a retrospective cohort study[J]. Am J Kidney Dis, 2022, 79(5): 626-634.
doi: 10.1053/j.ajkd.2021.07.013 |
| [40] |
Mai K, Singer P, Fahmy AE, et al. Kidney transplant outcomes in children and adolescents with systemic lupus erythematosus[J]. Pediatr Transplant, 2022, 26(1): e14178.
doi: 10.1111/petr.v26.1 |
| [41] |
Gipson DS, Ferris ME, Dooley MA, et al. Renal transplantation in children with lupus nephritis[J]. Am J Kidney Dis, 2003, 41(2): 455-463.
pmid: 12552510 |
| [42] |
Rangoonwala S, Marks SD. Kidney transplantation outcomes for children and young people with lupus nephritis[J]. Pediatr Transplant, 2022, 26(1): e14193.
doi: 10.1111/petr.v26.1 |
| [1] | LIN Jinfeng, CHEN Yi, DENG Yan, FENG Ai, HUANG Juan, CHEN Lizhu, XIE Jingqi, NIE Xiaojing. A comparative study on the detection of anti-Nephrin antibodies in children's nephrotic syndrome by chemiluminescence method and cell-based assay [J]. Journal of Clinical Pediatrics, 2026, 44(8): 682-689. |
| [2] | ZHENG Fangyuan, WANG Miao, DING Mingming, LU Aidong, JIA Yueping, ZENG Huimin, ZHANG Leping. Next-generation sequencing identified gene variants and their prognostic impact in pediatric Philadelphia chromosome positive acute lymphoblastic leukemia [J]. Journal of Clinical Pediatrics, 2026, 44(8): 690-697. |
| [3] | ZHANG Xiao, FANG Hongjun, KUANG Xiaojun, WANG Lijuan, WU Zhao, JIANG Sha, LI Pei, WU Liwen. Analysis of the clinical and electrophysiological characteristics of atonic seizures in children [J]. Journal of Clinical Pediatrics, 2026, 44(8): 698-704. |
| [4] | WANG Mengqian, YANG Hui. Case series analysis of 13 intestinal Behcet’s syndrome in children [J]. Journal of Clinical Pediatrics, 2026, 44(8): 705-711. |
| [5] | WU Xirong, GAO Qi, GUO Siyuan, YIN Qingqin, QIN Qiang, YIN Ju, JIAO Anxia, CHEN Chenghao, WU Di, WANG Bei, DUAN Xiaomin, PENG Yun, XU Baoping, GAO Liwei. Clinical characteristics and prognosis of pulmonary mucormycosis in children with diabetes mellitus [J]. Journal of Clinical Pediatrics, 2026, 44(8): 712-720. |
| [6] | HAN Yanan, GE Lanlan, CUI Jieyuan. A case report of branchio-oto-renal syndrome caused by EYA1 gene variant with a 6-year follow-up [J]. Journal of Clinical Pediatrics, 2026, 44(8): 721-726. |
| [7] | SHI Jiayi, GAO Chunlin, JIA Lili, LU Yunyun, SUN Tao, ZHU Xiaodong, XIA Zhengkun, ZHANG Pei. Phenotypic characteristics and prognostic analysis of a pedigree with childhood isolated nephrotic syndrome caused by compound heterozygous mutations in the COQ2 gene [J]. Journal of Clinical Pediatrics, 2026, 44(8): 727-732. |
| [8] | CHENG Yuheng, XU Zizhao, CHEN Ying. Recent advances in the diagnosis and treatment of X-linked hypophosphatemic rickets [J]. Journal of Clinical Pediatrics, 2026, 44(8): 747-754. |
| [9] | Rachel Rosen, Osvaldo Borrelli, Christophe Faure, Katja Karrento, Usha Krishnan, Samuel Nurko, Nathalie Rommel, Alan Silverman, Michiel van Wijk, Marc Benninga (Author), Chinese Medical Association Parenteral and Enteral Nutrition Branch Pediatrics Group, The Subspecialty Group of Gastroenterology, The Society of Pediatric, Chinese Medical Association, Gastroenterology Group, Pediatrician Branch, Chinese Medical Doctor Association (Translator). Core interpretation and explanation of Rome Ⅴ diagnostic criteria: upper gastrointestinal disorders of gut-brain interaction in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(7): 595-608. |
| [10] | Carlo Di Lorenzo, Miguel Saps, Bruno P. Chumpitazi, Shaman Rajindrajith, Annamaria Staiano, Nikhil Thapar, Miranda van Tilburg, Carlos Velasco-Benítez, Arine Vlieger (Author), Chinese Medical Association Parenteral and Enteral Nutrition Branch Pediatrics Group, The Subspecialty Group of Gastroenterology, The Society of Pediatric, Chinese Medical Association, Gastroenterology Group, Pediatrician Branch, Chinese Medical Doctor Association (Translator). Core interpretation and explanation of Rome Ⅴ diagnostic criteria: lower and biliary disorders of gut-brain interaction in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(7): 609-621. |
| [11] | LI Xufeng, TANG Haoxun, LI Xingjun, ZHANG Lize, GAO Chenqing, ZHAO Shunying, LIU Jianhua. Clinical characteristics, chest CT imaging phenotypes, and their correlation with prognosis in 76 children with Chlamydia pneumoniae pneumonia [J]. Journal of Clinical Pediatrics, 2026, 44(7): 622-627. |
| [12] | WANG Zhen, SHAO Jingbo, ZHANG Na, XIA Min, ZHU Jiashi, DU Chengkan, LI Hong. Factors influencing long-term recurrence in pediatric acute lymphoblastic leukemia patients with low-risk disease at initial diagnosis: a five-year follow-up analysis of 254 cases from a single center [J]. Journal of Clinical Pediatrics, 2026, 44(7): 628-635. |
| [13] | GUO Xuemei, XUE Yao, WANG Yongren, RONG Liucheng, FANG Yongjun, LIN Rufeng. Clinical features and prognosis of childhood acute myeloid leukemia with CBFA2T3::GLIS2 fusion [J]. Journal of Clinical Pediatrics, 2026, 44(7): 636-643. |
| [14] | YANG Lijun, FU Dongxia, CUI Yan, YANG Junmei, ZHANG Liming. Clinical manifestation and genetic analysis of CHARGE syndrome caused by CHD7 gene variation [J]. Journal of Clinical Pediatrics, 2026, 44(7): 644-650. |
| [15] | HU Yan, YANG Fan, LIANG Aimin, MAO Meng. Identification and management of faltering growth in children: insights from the 13th International Conference on Nutrition and Growth [J]. Journal of Clinical Pediatrics, 2026, 44(6): 485-488. |
|
||